Social media and medicines information; impact on antibiotics misunderstanding and misuse

6 April 2010

A further thought on the impact of social media on health care and health information comes from a study today in the USA. A report in the American Journal of Infection Control, titled Dissemination of health information through social networks: Twitter and antibiotics.

Speaking on "Good Morning America", the study's co-author Daniel Scanfeld said: "When we looked at tweets...we found that there are some basic categories like general mentioning of antibiotics or complaints about side effects and things like that, but there was also a category that was pretty interesting, where people were indicating misuse or misunderstanding of antibiotics."

According to the blog page of the European Federation of Pharmaceutical Industries and Associations (EFPIA), he added that "one tweet indicating misuse of antibiotics could be spread potentially to hundreds of thousands of people via the Twitter network."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical